Navigation Links
Accredited Construct Specific PCR Test for Recently Detected Unapproved GM Flax/Linseed FP967/CDC Triffid Available Through Genetic ID
Date:9/22/2009

AUGSBURG, Germany, September 22 /PRNewswire/ -- Subsequent to the announcement of the EU Rapid Alert System for Food and Feed on 8 September 2009, the German surveillance lab in the state of Baden-Wurttemberg has confirmed the detection of GM linseed/flax variety FP967/CDC Triffid, which is unapproved in the EU.

Additionally, there have been additional EU Rapid Alert announcements regarding the presence of FP967/CDC Triffid in food products distributed to Germany, Italy, Luxembourg, Netherlands, Belgium, and Switzerland. These discoveries have been widely covered by the media globally during the past several days. This unapproved GM flax was detected in a wide variety of flax/linseed products including cereals, bakery products, nut products and seeds.

Having developed the first detection method for construct present in FP967/CDC Triffid, Genetic ID now offers this specific and accredited test worldwide. German surveillance laboratories also use the Genetic ID method to detect this GMO linseed.

This GMO variety originates from the Crop Development Centre Canada at the University of Saskatchewan. Canada supplies approximately 70% of the total flax utilized in the EU annually.

Since neither a safety assessment by the EU nor an application for approval has been submitted for this GMO, the zero tolerance rule applies. This means any raw material or flax/linseed derivative analyzed to be positive for FP967/CDC Triffid is illegal and not marketable in the EU.

Genetic ID developed this test according to the guidelines of the EU Joint Research Centre, and includes this test in its accreditation scope under DIN EN ISO 17025. The JRC has now made the Genetic ID method available to all members of the European Network of GMO Laboratories (ENGL).

Genetic ID provides the food, animal feed and agricultural industry worldwide a full range of GMO testing services from its laboratories in Germany, Japan, USA and through its Global Laboratory Alliance.

http://www.genetic-id.de

Call the EU GM flax test information hotline: +49-821-747-76-30


'/>"/>
SOURCE Genetic ID (Europe) AG
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Enerkem Announces Construction Start on Advanced Energy Research Facility in Edmonton, Alberta
2. Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat Patients With Non-Reconstructable Critical Limb Ischemia
3. Vega Picks Tennessee Firm to Assist with Construction of Biomass Plant in Georgia
4. Sinovac Completes Construction of H1N1 Virus Seed Bank
5. Secret of sandcastle construction could help revive ancient building technique, researchers say
6. Sandia researchers construct carbon nanotube device that can detect colors of the rainbow
7. NanoLogix Begins Construction of Production Facility for Medical Test Kits
8. Mach One Subsidiary Modular Process Constructors LLC Changes Name to MPS BioPharm to Better Reflect its Vision
9. New Generation Biofuels Completes Construction of Baltimore Facility
10. Asbestos, Pharmaceutical Liability, Construction Defects, Nanotech: Covered by Targeted CLE Teleconferences
11. Max Planck Institute of Biochemistry Uses MathWorks Tools in Its Quest to Cure Cancer : Institute Accelerates Reconstruction of Key Protein Complexes Using MATLAB and Parallel Computing Toolbox
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... (PRWEB) , ... April 20, 2017 , ... Parallel6™ ... clinical trials worldwide, announced today that they were named one of the 2017 ... covers the latest developments in the pharmaceutical industry. , “We take pride in honoring ...
(Date:4/20/2017)... For today, Stock-Callers.com redirects investors, attention to Biotechnology, ... research aimed at treating diseases and medical conditions. Under evaluation ... (NASDAQ: KERX), Kite Pharma Inc. (NASDAQ: KITE), and ZIOPHARM Oncology ... complimentary research reports on these stocks now at: ... http://stock-callers.com/registration Biostage ...
(Date:4/19/2017)... ... April 18, 2017 , ... Optofluidics today announced that ... after the company changed focus to making analytical tools for biopharmaceutical quality control. ... technology,” says CEO Robert Hart. Founders Bernardo Cordovez, Robert Hart and David Erickson ...
(Date:4/19/2017)... ... April 19, 2017 , ... As part of ... accessible to novices as well as experienced users, attendees will gain a better ... screening tests. , Hemostasis testing quality is determined by preanalytical variables which ...
Breaking Biology Technology:
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
(Date:3/29/2017)...  higi, the health IT company that operates the ... , today announced a Series B investment from ... The new investment and acquisition accelerates higi,s strategy to ... population health activities through the collection and workflow integration ... collects and secures data today on behalf of over ...
Breaking Biology News(10 mins):